Relmada Therapeutics GAAP EPS of -$0.27 misses by $0.13 (NASDAQ:RLMD)
Relmada Therapeutics(US:RLMD) Seeking Alpha·2026-03-19 20:06Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below ...